BUSINESS

• Eisai to Raise 50 Billion Yen via Bond Issue for R&D, Licensing
  June 5, 2026

• Japan Market for Fertility, Contraception, Female Disorders Put at 228.5 Billion Yen by FY2035
  June 5, 2026

• Toho, DHL Partner on Healthcare Logistics Platform
  June 5, 2026

• Keytruda Maintains Lead as Japan’s Top-Selling Drug for 32nd Month: Encise
  June 5, 2026

• Boehringer’s Japan Pharma Sales Up for 7th Straight Year, 10-Plus Launches Eyed by 2030
  June 4, 2026

• Sato Bets on Solo Nailin Promotion, Hospital Push to Drive Dermatology Growth
  June 4, 2026

• Nitrosamine Detected in Viatris’ Jzoloft OD Tablets
  June 4, 2026

• RaQualia, RIKEN Team Up on Drug Discovery Technologies
  June 4, 2026

• AbbVie Japan Says Sales-Doubling Plan on Track as Revenue Climbs 13.5%
  June 3, 2026

• FunPep, Crafton Join Forces on Therapeutic mRNA Vaccines
  June 3, 2026

• Shionogi’s Xocova Scores US FDA Nod for COVID-19 PEP
  June 3, 2026

• J&J’s Tremfya Now Available for Self-Injection in IBD
  June 2, 2026

• J&J Taps Leading Cancer Centers to Bolster Japan Trial Environment
  June 2, 2026

• BMS Files Breyanzi for Relapsed/Refractory CLL, SLL in Japan
  June 1, 2026

• Astellas Rebuts ISS Opposition to Outside Director Nominee
  June 1, 2026

• Meiji Backs US Fund Supporting Pandemic Preparedness
  June 1, 2026

• Kaken, Gilead Ink Japan Sales Partnership for Seladelpar
  June 1, 2026

• Shionogi’s OIC Drug Naldemedine Bags Approval in China
  June 1, 2026

• Eylea Bio-AG Snags 60% Share in Just 3 Months, Outpacing Biosimilar
  May 29, 2026

• FRONTEO, Scohia Team Up on AI-Driven Indication Discovery
  May 29, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »